Results 141 to 150 of about 1,498,446 (168)

[Antiparkinson agents. 50].

Pharmazeutische Praxis, 1971
F, Schmutzler, A, Eichhorn
openaire   +1 more source

Exploiting second-order advantage from mathematically modeled voltammetric data for simultaneous determination of multiple antiparkinson agents in the presence of uncalibrated interference

Journal of the Taiwan Institute of Chemical Engineers, 2018
Ghobad Mohammadi, Khodabakhsh Rashidi
exaly  

Effects of benapryzine, a new antiparkinson drug, on dopamine uptake into corpus striatum

European Journal of Pharmacology, 1974
Michael G Palfreyman
exaly  

Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities

American Journal of Geriatric Pharmacotherapy, 2006
Nicole Brandt, Becky A Briesacher
exaly  

Antiparkinson Drug Use and Adherence in Medicare Part D Beneficiaries With Parkinson’s Disease

Clinical Therapeutics, 2013
Yu-Jung Jenny Wei, Lisa Shulman, Bruce Stuart   +2 more
exaly  

[Anticholinergic antiparkinson agents].

Soins. Psychiatrie, 1989
openaire   +1 more source

Antiparkinson agent/Quetiapine/Sertraline

Reactions Weekly
openaire   +1 more source

Parkinson’s disease, antiparkinson medicines, and driving

Expert Review of Neurotherapeutics, 2016
F Javier Alvarez
exaly  

Antiparkinson Drug Adherence and Its Association with Health Care Utilization and Economic Outcomes in a Medicare Part D Population

Value in Health, 2014
Yu-Jung Jenny Wei, Lisa Shulman, Clayton Brown   +2 more
exaly  

Transdermal delivery of antiparkinson agents

2004
KLOSE KATHRYN TRACI-JANE, TRAN NGAN THI KIM, MORGON TIMOTHY MATTHIAS, FINNIN BARRIE CHARLES, REED BARRY LEONARD   +4 more
openaire   +2 more sources